From: Stromal proteome expression profile and muscle-invasive bladder cancer research
Pathway | Gene name |
---|---|
Metabolic pathways | ACAA1, ACADSB, ACO2, ACOX1, ACSL5, ACSM1, ACSM3, ADH1B, ADSS, AK2, AKR1B10, ALDH1B1, ALDH4A1, APIP, APRT, ASAH1, ATIC, ATP5I, ATP6V1E1, BCKDHA, BCKDHB, CAT, CBS, CHPF, COMT, COX17, COX5B, CS, CYC1, CYP19A1, DAD1, DBT, DDOST, DGKI, DLAT, DLD, DLST, DUT, FASN, FH, G6PD, GANAB, GNPDA1, GOT2, GRHPR, HADH, HADHB, HIBADH, HK1, HMGCL, HMGCS2, HSD17B4, IDH1, IMPDH2, ITPA, ITPKA, LAP3, MAT2A, NANS, NDUFA10, NDUFA4, NDUFA8, NDUFS4, NDUFS6, NFKB1, NME2, NOS3, OGDH, Cav-1, PAICS, PCK2, PDXK, PFKP, PGD, PGM2, PHPT1, PNPO, POLR2D, PRDX6, SDHB, SPTLC1, SUCLG2, TYMP, UGDH, UQCRB, UQCRC1 |
Spliceosome | ACIN1, BCAS2, CRNKL1, HNRNPA1, HSPA2, HSPA6, NHP2L1, PUF60, RBM8A, RBMX, SF3A3, SF3B1, SF3B2, SFRS13A, SFRS2, SFRS3, SFRS4, SFRS5, SFRS9, SNRNP200, SNRPB, SNRPC, SNRPD3, SNRPF, SNRPG, TRA2B, U2AF2 |
Regulation of actin cytoskeleton | ARPC1B, ARPC2, ARPC3, ARPC5, CDC42, CFL2, CRK, ENAH, IQGAP3, ITGA5, ITGA6, ITGAV, ITGB1, ITGB4, MYH14, MYLK, PIK3CB, ROCK2, RRAS2, SSH1, SSH3, WASF2 |
Ribosome | RPL18, RPL19, RPL22, RPL23, RPL23A, RPL31, RPL38, RPL5, RPL7A, RPL9, RPLP0, RPLP1, RPS10, RPS17, RPS20, RPS25, RPS4X, RPS7 |
Focal adhesion | CDC42, COL3A1, COL4A2, CRK, CTNNB1, FLNC, FLT1, ITGA5, ITGA6, ITGAV, ITGB1, ITGB4, MYLK, PIK3CB, RAP1B, ROCK2, TNC, TNXB, VTN, VWF |
Proteasome | PSMA3, PSMA4, PSMA5, PSMA7, PSMB2, PSMB7, PSMC1, PSMC2, PSMC4, PSMC6, PSMD2, PSMD7, PSME2 |
Endocytosis | ACAP2, ARFGAP2, CDC42, CHMP5, CLTA, CLTB, DNM2, EEA1, EHD1, EHD2, EHD4, EPN1, FLT1, HLA-C, HSPA2, HSPA6, PDCD6IP, RAB11B, RAB11FIP1, VTA1 |
Huntington's disease | CASP8, CLTA, CLTB, COX5B, COX7A2, CYC1, CYCS, DCTN1, NDUFA10, NDUFA4, NDUFA8, NDUFS4, NDUFS6, POLR2D, SDHB, SOD1, TAF4, UQCRB, UQCRC1 |
Alzheimer's disease | ADAM10, APOE, ATP2A3, CAPN1, CASP8, COX5B, COX7A2, CYC1, CYCS, LRP1, NDUFA10, NDUFA4, NDUFA8, NDUFS4, NDUFS6, PPP3R1, SDHB, UQCRB, UQCRC1 |
Oxidative phosphorylation | ATP5I, ATP6V1E1, COX17, COX5B, COX7A2, CYC1, NDUFA10, NDUFA4, NDUFA8, NDUFS4, NDUFS6, PPA1, SDHB, UQCRB, UQCRC1 |
Systemic lupus erythematosus | C8G, C9, CTSG, ELANE, H2AFV, H2AFY, HIST1H2AA, HIST1H2BA, HIST2H3A, HIST2H3C, HIST2H3D, HLA-DRB1, SNRPB, SNRPD3, SSB |
Valine, leucine and isoleucine degradation | ACAA1, ACADSB, ALDH1B1, BCKDHA, BCKDHB, DBT, DLD, HADH, HADHB, HIBADH, HMGCL, HMGCS2 |
Pathogenic Escherichia coli infection | ARPC1B, ARPC2, ARPC3, ARPC5, CDC42, CDH1, CTNNB1, CTTN, HCLS1, ITGB1, ROCK2, TUBB3 |
ECM-receptor interaction | AGRN, COL3A1, COL4A2, ITGA5, ITGA6, ITGAV, ITGB1, ITGB4, TNC, TNXB, VTN, VWF |
Complement and coagulation cascades | C4BPA, C8G, C9, CFH, CFI, KNG1, PLG, SERPINC1, SERPING1, VWF |
Citrate cycle | ACO2, CS, DLAT, DLD, DLST, FH, IDH1, OGDH, PCK2, SDHB, SUCLG2 |